- Home
- PTGX vs GTX Comparison
PTGX vs GTX Comparison
Compare PTGX & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | GTX |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 3.5B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PTGX | GTX |
|---|---|---|
| Price | $99.57 | $33.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 5 |
| Target Price | ★ $108.23 | $20.40 |
| AVG Volume (30 Days) | 492.5K | ★ 3.1M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 20.63 |
| EPS | 0.05 | ★ 0.49 |
| Revenue | N/A | ★ $3,584,000,000.00 |
| Revenue This Year | $874.25 | $4.16 |
| Revenue Next Year | N/A | $3.27 |
| P/E Ratio | $2,044.80 | ★ $67.91 |
| Revenue Growth | N/A | ★ 3.14 |
| 52 Week Low | $45.28 | $9.58 |
| 52 Week High | $107.84 | $33.38 |
Technical Indicators
Market Signals| Indicator | PTGX | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.37 | 80.21 |
| Support Level | $96.20 | $17.01 |
| Resistance Level | $100.00 | N/A |
| Average True Range (ATR) | 4.42 | 1.32 |
| MACD | -0.22 | 0.25 |
| Stochastic Oscillator | 29.88 | 89.24 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.